These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1649359)

  • 1. [Thromboembolic disease and thrombocytopenia associated with the use of low-molecular weight heparins].
    Bóveda Treviño JL; Gràcia Gozalo RM; Barrabés J; Monasterio J
    Med Clin (Barc); 1991 May; 96(18):718-9. PubMed ID: 1649359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-associated thrombocytopenia caused by low-molecular-weight heparin].
    Köninger J; Greinacher A; Müller-Beissenhirtz W; Strosche H
    Unfallchirurg; 1995 Jan; 98(1):49-51. PubMed ID: 7886465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring and management of heparin-induced thrombocytopenia.
    Rogers B; Little Nj; Jones C
    Br J Hosp Med (Lond); 2009 Nov; 70(11):630-3. PubMed ID: 20081589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Revival and adverse effects of heparin therapy: low molecular weight heparins; thrombogenic thrombopenias].
    Larcan A; Laprevote-Heully MC; Toulemonde F
    Bull Acad Natl Med; 1986 Apr; 170(4):541-9. PubMed ID: 3536016
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin induced thrombocytopenia after low molecular weight heparin treatment: a case report.
    Illuminati G; Caliò FG; Bertagni A; Forte A; Gallinaro L; Montesano G; Ciulli A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):225-8. PubMed ID: 9177626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of heparin-induced thrombocytopenia with fondaparinux.
    Harenberg J; Jörg I; Fenyvesi T
    Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
    Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
    Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins--a safer option than unfractionated heparin?
    McKay GA; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):256-76. PubMed ID: 11770172
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non controlled prospective study of the efficacy and tolerance of a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    J Mal Vasc; 1991; 16(4):367-71. PubMed ID: 1665169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocytopenia induced by low molecular weight heparin].
    Ríos Herranz E; Briz Blanco M; Cabrera Marín JR; Fernández Rodríquez MN
    Med Clin (Barc); 1991 Apr; 96(16):635-6. PubMed ID: 1646919
    [No Abstract]   [Full Text] [Related]  

  • 13. Why low molecular weight heparin?
    Mammen EF
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():1-4. PubMed ID: 1962897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombopenia caused by low molecular weight heparin].
    Tardy B; Page Y; Tardy-Poncet B; Comtet C; Zeni F; Bertrand JC
    Therapie; 1990; 45(5):453. PubMed ID: 2175456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombopenia induced by a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    Cah Anesthesiol; 1990; 38(3):175-7. PubMed ID: 2169975
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins in acute coronary syndromes.
    Cohen M
    Semin Hematol; 1999 Jan; 36(1 Suppl 1):33-6. PubMed ID: 9930562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonbleeding complications of unfractionated and low-molecular weight heparins.
    Eikelboom J
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):871-3. PubMed ID: 18185483
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.